NuGen Medical Devices Inc.
NGMD.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.17M | -694.90K | -1.35M | -1.89M | -1.70M |
| Total Depreciation and Amortization | 114.00K | 116.80K | 127.80K | 112.20K | 133.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 630.60K | 203.40K | 291.70K | 549.80K | 232.40K |
| Change in Net Operating Assets | 769.60K | 217.90K | 331.90K | 350.10K | 657.90K |
| Cash from Operations | -655.10K | -156.80K | -603.30K | -880.00K | -678.50K |
| Capital Expenditure | -- | -- | -- | -2.20K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -300.00 | -300.00 | -300.00 | -37.00K | -37.30K |
| Cash from Investing | -300.00 | -300.00 | -300.00 | -39.20K | -37.30K |
| Total Debt Issued | 10.00M | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -7.00K | -20.80K | 10.00K | -30.50K |
| Issuance of Common Stock | 65.00K | 0.00 | 765.00K | 40.00K | 1.35M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.38M | -5.10K | 552.00K | 36.70K | 983.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 32.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.72M | -162.20K | -51.60K | -882.50K | 299.90K |